FDA Inspection 1064901 — AmerisourceBergen Drug Corporation
The FDA completed an inspection of AmerisourceBergen Drug Corporation on August 20, 2018 in Lockbourne, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 20, 2018
- Fiscal Year
- 2018
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Lockbourne, OH (United States)